According to GlobalData’s medical device pipeline database, 202 Vision Care devices are in various stages of development globally. GlobalData’s report Vision Care provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 123 are in active development, while the remaining 82 are in an inactive stage of development. There are 65 products in the early stages of development, and the remaining 58 are in the late stages of development.
Ophthalmic devices are used for vision correction or in ophthalmic diagnostic procedures. Vision care market covers therapeutic accessories in ophthalmology to enhance patient’s vision outcome. These include contact lenses, spectacles lenses and contact lens cleaning and disinfecting solutions.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Vision Care pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Vision Care devices. Overall, most of these Vision Care pipeline devices are being developed by private entities.
Key players involved in the active development of Vision Care include Bausch & Lomb, Visioneering Technologies, Alcon, Alcon Laboratories, Ai Kangte Medical Technology, Lentechs, Nunaps, Johnson & Johnson Vision Care, Lynthera and Tsubota Laboratory.
For a complete picture of the developmental pipeline for Vision Care devices, buy the report here.